SK
Therapeutic Areas
Enliven Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ELVN-001 | Chronic Myeloid Leukemia (CML) | Phase 1b |
Leadership Team at Enliven Therapeutics
RF
Rick Fair
Chief Executive Officer and Member of the Board of Directors
JL
Joe Lyssikatos
Co-founder and Chief Scientific Officer
AP
Anish Patel
Co-founder and Chief Operating Officer
HC
Helen Collins
Chief Medical Officer
BH
Ben Hohl
Chief Financial Officer and Head of Corporate Development
GB
Galya Blachman
Chief Legal Officer and Head of Business Development